Literature DB >> 30289073

VEGFR2 and VEGF-C Suppresses the Epithelial-Mesenchymal Transition Via YAP in Retinal Pigment Epithelial Cells.

Y Du1, Q Chen1, L Huang1, S Wang1, X Yin1, L Zhou1, Z Ye1, X Ren1, Y Cai2, X Ding1, H Ouyang1, X Li1, R Ju1.   

Abstract

BACKGROUND: Whereas retinal pigment epithelial (RPE) cells are known to secrete VEGF-A and VEGFR2, the functions of the autocrine VEGF signaling remain unclear. Meanwhile, anti-VEGF therapies have been applied routinely to treat ocular vascular diseases.
OBJECTIVE: The aim of this study was to determine the functions of the VEGF signaling in RPE cells and evaluate the consequences of its interruption.
METHODS: The genes involved in the VEGF and Hippo signal pathways were knocked down with siRNAs in both ARPE-19 cell line and human primary RPE cells via transient transfection whereas overexpression of VEGFR2 was mediated via adenovirus transduction. Expression of the epithelial-mesenchymal transition (EMT) markers and the downstream genes of YAP were determined by real-time PCR and Western Blot analysis. Immunofluorescence staining was utilized to determine gene expression in tissue and mouse samples.
RESULTS: Knockdown of VEGFR2 results in epithelial-mesenchymal transition in vitro and in vivo. Overexpression of VEGFR2 suppresses TGF β-mediated EMT in RPE cells. Loss of VEGF-C rather than VEGF-A induces EMT. Mechanistically, the VEGFR2 ablation-induced EMT in RPE cells is mediated by activation of YAP, an effector of the Hippo pathway. Finally, the immunohistochemical analysis of VEGFR2 and YAP in human proliferative vitreoretinopathy (PVR) membranes indicates a tendency of an inverse correlation between VEGFR2-positive and YAP-positive cells.
CONCLUSIONS: Our results disclose unexpected novel roles of VEGFR2 and VEGF-C in the process of EMT of RPE cells and in the Hippo pathway. The data shown here demonstrated that VEGFR2 and VEGF-C are important to maintain the normal physiological state of RPE cells. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Hippo pathway; Retinal pigment epithelial cell; VEGFR2; epithelial-mesenchymal transition; eye; vascular endothelial growth factor; yes-associatedzzm321990protein.

Mesh:

Substances:

Year:  2018        PMID: 30289073     DOI: 10.2174/1566524018666181004115304

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  5 in total

1.  Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study.

Authors:  Nan Geng; Cui-Min Ding; Zhi-Kun Liu; Shan Song; Wen-Xia Hu
Journal:  Int J Clin Oncol       Date:  2021-01-03       Impact factor: 3.402

2.  Protein Kinase A Inhibitor H89 Attenuates Experimental Proliferative Vitreoretinopathy.

Authors:  Yali Lyu; Wei Xu; Jieping Zhang; Mengwen Li; Qingyi Xiang; Yao Li; Tianhao Tan; Qingjian Ou; Jingfa Zhang; Haibin Tian; Jing-Ying Xu; Caixia Jin; Furong Gao; Juan Wang; Weiye Li; Ao Rong; Lixia Lu; Guo-Tong Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

3.  Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells.

Authors:  Yu Mao; Yimin Wang; Lixin Dong; Yunjie Zhang; Yanqiu Zhang; Chao Wang; Qiang Zhang; Sen Yang; Liyan Cao; Xinyuan Zhang; Xin Li; Zhanzhao Fu
Journal:  J Exp Clin Cancer Res       Date:  2019-09-05

4.  Role of VEGFR2 in Mediating Endoplasmic Reticulum Stress Under Glucose Deprivation and Determining Cell Death, Oxidative Stress, and Inflammatory Factor Expression.

Authors:  Bohan Xu; Linbin Zhou; Qishan Chen; Jianing Zhang; Lijuan Huang; Shasha Wang; Zhimin Ye; Xiangrong Ren; Yu Cai; Lasse Dahl Jensen; Weirong Chen; Xuri Li; Rong Ju
Journal:  Front Cell Dev Biol       Date:  2021-06-18

5.  MicroRNAs in the Vitreous Humor of Patients with Retinal Detachment and a Different Grading of Proliferative Vitreoretinopathy: A Pilot Study.

Authors:  Mario Damiano Toro; Michele Reibaldi; Teresio Avitabile; Claudio Bucolo; Salvatore Salomone; Robert Rejdak; Katarzyna Nowomiejska; Sarah Tripodi; Chiara Posarelli; Marco Ragusa; Cristina Barbagallo
Journal:  Transl Vis Sci Technol       Date:  2020-05-22       Impact factor: 3.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.